C1S.F China Shineway Pharmaceutical Group Limited

Healthcare Pharmaceuticals Frankfurt Exchange
0.8700 EUR
Close of Nov 11, 2026
0.6138 0.8700
Market cap
EUR 657M
P/E
6.7x
P/B
0.59x
ROE
11.8%
Dividend yield
18.58%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is C1S.F undervalued?

Graham number
Price0.8700
Graham value2.07
Discount58.0%

C1S.F trades 58.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

China Shineway Pharmaceutical Group Limited fundamental analysis

No fundamental analysis for China Shineway Pharmaceutical Group Limited yet.

China Shineway Pharmaceutical Group Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, …

Full company profile